GCP
TVTX icon

GSA Capital Partners’s Travere Therapeutics TVTX Stock Holding History

GSA Capital Partners’s Portfolio TVTX Stock Details TVTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-88,195
Closed -$1.3M – 2108
2025
Q2 		$1.3M Buy
+88,195
New +$1.46M 0.09% 306
2025
Q1 		– Sell
-74,356
Closed -$1.29M – 2087
2024
Q4 		$1.29M Buy
+74,356
New +$1.32M 0.1% 250
2024
Q2 		– Sell
-58,601
Closed -$452K – 2033
2024
Q1 		$452K Buy
+58,601
New +$494K 0.04% 948
2021
Q1 		– Sell
-41,806
Closed -$1.14M – 1503
2020
Q4 		$1.14M Buy
+41,806
New +$976K 0.19% 100
2018
Q4 		– Sell
-11,600
Closed -$333K – 1741
2018
Q3 		$333K Buy
+11,600
New +$332K 0.02% 1273
2018
Q1 		– Sell
-28,100
Closed -$592K – 1834
2017
Q4 		$592K Buy
28,100
+16,400
+140% +$375K 0.04% 857
2017
Q3 		$291K Sell
11,700
-2,700
-19% -$59.5K 0.02% 1274
2017
Q2 		$279K Buy
+14,400
New +$261K 0.02% 1323
2017
Q1 		– Sell
-33,245
Closed -$629K – 1999
2016
Q4 		$629K Buy
33,245
+14,345
+76% +$293K 0.04% 847
2016
Q3 		$423K Sell
18,900
-27,609
-59% -$526K 0.02% 1152
2016
Q2 		$828K Buy
46,509
+18,920
+69% +$306K 0.05% 753
2016
Q1 		$377K Buy
+27,589
New +$419K 0.02% 1176
2015
Q4 		– Sell
-48,990
Closed -$993K – 1971
2015
Q3 		$993K Buy
48,990
+39,470
+415% +$1.17M 0.05% 635
2015
Q2 		$316K Buy
+9,520
New +$261K 0.01% 1590
2014
Q4 		– Sell
-30,444
Closed -$275K – 1902
2014
Q3 		$275K Buy
+30,444
New +$358K 0.01% 1318

Other funds holding TVTX

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

GSA Capital Partners's TVTX Position: Q3 2025 in Review

GSA Capital Partners sold out of Travere Therapeutics (TVTX) in Q3 2025, closing a stake of 88,195 shares — an estimated $1.3M sold.

GSA Capital Partners first reported a position in TVTX in Q3 2014 and held it in 15 quarters. The position peaked at $1.3M in Q2 2025. 238 funds tracked by Wall St. Rank hold TVTX as of Q3 2025.

  • GSA Capital Partners reported no remaining Travere Therapeutics position as of Q3 2025 after selling out during the quarter.
  • GSA Capital Partners sold 88,195 Travere Therapeutics shares in Q3 2025, an estimated $1.3M.
  • GSA Capital Partners first reported a position in Travere Therapeutics in Q3 2014 and held it in 15 quarters.
  • GSA Capital Partners's Travere Therapeutics position peaked at $1.3M in Q2 2025.
  • 238 funds tracked by Wall St. Rank held Travere Therapeutics as of Q3 2025.

Based on GSA Capital Partners's 13F filing for Q3 2025, filed 7 Nov 2025.